Idera Pharmaceuticals, Inc. (IDRA) Reports Q4 Loss of $0.35/Share

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 EPS of ($0.35), versus ($0.21) reported last year.

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance